| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| terazosin | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.53 | approved | antagonist |
| terazosin | alpha-1b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.57 | approved | antagonist |
| terazosin | adrenergic receptor alpha-1d | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | unknown |
| terazosin | alpha-1d adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| terazosin | adrenergic receptor alpha-1d | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| terazosin | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| terazosin | potassium voltage-gated channel subfamily h member 6 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| terazosin | potassium voltage-gated channel subfamily h member 7 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| terazosin | transforming growth factor beta-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inducer |
| click here to return to the previous page | ||||||||